Skip to main content
SpringerLink
Log in
Book cover

Forschungen zur Biologischen Psychiatrie pp 85–92Cite as

Güteeigenschaften gerontopsychiatrischer Skalen

  • Conference paper

  • 16 Accesses

Zusammenfassung

Aufgrund des Gesetzes zur Neuordnung des Arzneimittelrechtes wurde durch den Bundesminister für Jugend, Familie und Gesundheit eine Kommission „Alterskrankheiten und Schwächezustände“ berufen. Diese Kommission hat ein Projekt initiiert, in dem es um die Erfassung und kritische Bewertung von Methoden für die Gerontopharmakologie geht. Absicht dieses Vorhabens sollte es sein, der forschenden Pharmaindustrie Empfehlungen für die Durchführung von klinischen Prüfungen mit sog. Gerontopharmaka zu geben, und dem BGA sollte es Maßstäbe für die Bewertung solcher Studien liefern. Neben Leistungsmaßen, biochemischen und EEG-Methoden ging es um gerontopsychiatrische Skalen, von denen wir hier nur die Fremdratings behandeln. Bezogen auf das Thema nehmen wir noch eine weitere Beschränkung vor, indem wir aus dem Feld möglicher Gültigkeiten die Gerontopharmakologie besonders gewichten.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Amery WK, Oosterveld WJ (1975) An evaluation of cinnarizine in aged patients with vertigi-nous complaints — a multicentre trial. Acta Ther 1: 39–48

    Google Scholar 

  2. Arrigo A, Braun P, Kauchtschischwili GM, Moglia A, Tartara A (1973) Influence of treatment on symptomatology and correlated electroencephalographic ( EEG) changes in the aged. Curr Ther Res 15: 417–426

    PubMed  CAS  Google Scholar 

  3. Banen DM (1972) An ergot preparation (hydergine) for relief of symptoms of cerebrovascular insufficiency. J Am Geriatr Soc 20 1: 22–24

    PubMed  CAS  Google Scholar 

  4. Bargheon J (1973) Etude en double insu de l’hydergine chez le sujet âgé. Nouv Presse Méd 2 /31

    Google Scholar 

  5. Bargheon J (1975) Doppelblindversuch mit Praxilene in der Geriatrie. Gaz Med Fr 82 /40

    Google Scholar 

  6. Bargheon J (1975) Essai en double aveugle du praxilène en gériatrie. Gaz Med Fr 82 /40: 4755–4758

    Google Scholar 

  7. Bazo AJ (1973) An ergot alkaloid preparation (hydergine) versus papaverine in treating common complaints of the aged: Double-blind study. J Am Geriatr Soc 21 /2: 63–71

    PubMed  CAS  Google Scholar 

  8. Bente D, Glatthaar G, Ulrich G, Lewinsky M (1979) Nicergolin Arzneimittelforsch 29/11

    Google Scholar 

  9. Berde B, Schild HO (1980) Pharmakologie und klinische Pharmakologie von Hydergin. Springer, Berlin Heidelberg New York

    Google Scholar 

  10. Bernard A, Goffart JM (1968) A double-blind cross-over clinical evaluation of cinnarizine. Clin Trials J (London) 5 /1: 945–948

    Google Scholar 

  11. Biel M-L, Seus R, Struppler A (1976) Medikamentöse Therapie des hirnorganischen Psychosyndroms im Alter. Med Klin 71: 2177–2184

    PubMed  CAS  Google Scholar 

  12. Caird FI (1977) Computerized tomography (EMISCAN) in brain failure in old age. Age Ageing [Suppl] 6: 50–55

    Google Scholar 

  13. Capote B, Parikh N (1978) Cyclandelate in the treatment of senility: A controlled study. J Am Geriatr Soc 26 /8: 360–362

    PubMed  CAS  Google Scholar 

  14. Ciompi L, Kanowski S (1981) Dokumentationssystem der Arbeitsgemeinschaft für Geronto Psychiatrie (AGP). In: CIPS (Hrsg) Internationale Skalen für die Psychiatrie. Beltz, Weinheim

    Google Scholar 

  15. Cooper AJ, Magnus RV (1980) Eine plazebokontrollierte Untersuchung mit Pyritinol („Encephabol“) bei Demenz. Pharmatherapeutica 2: 317–322

    PubMed  CAS  Google Scholar 

  16. Cornbleth T (1978) Evaluation of goal attainment in geriatric settings. J Am Geriatr Soc 26 /9: 404–407

    PubMed  CAS  Google Scholar 

  17. Dorn M (1977) Zur Behandlung der zerebralen Insuffizienz in der Praxis. Therapiewoche 27: 2565–2573

    Google Scholar 

  18. Eckmann F (1976) Klinische Untersuchungen mit Piracetam. MMW 29 /30: 957–958

    Google Scholar 

  19. Einspruch BC (1976) Helping to make the final years meaningful for the elderly residents of nursing homes. Dis Nerv Syst 37: 439–442

    PubMed  CAS  Google Scholar 

  20. Engelmann G A (1975) Klinische Prüfung von Danaden retard bei Funktionspsychosen im Sinne leichter bis mittelschwerer Durchgangssyndrome. Med Welt 26: 1380–1384

    PubMed  CAS  Google Scholar 

  21. Fanchamps A (1979) Controlled studies with dihydroergotoxine in senile cerebral insufficiency. In: Nandy U (ed) Geriatric psychopharmacology. Elsevier North Holland, New York Oxford, pp 195–211

    Google Scholar 

  22. Ferreira AB, Ferreira AB, Souza TB (1973) Pharmakologische Behandlung der zerebralen Arteriosklerose mit einer neuen medikamentösen Kombination. Rev Bras Med 30 /2: 1–12

    Google Scholar 

  23. Freeman H, Murray P (1966) Treatment of aged psychotic patients with hydergine. Gerontol Clin 8: 279–284

    Article  CAS  Google Scholar 

  24. Gabrynowicz JW, Dumbrill M (1968) A clinical trial of leptazole with nicotinic acid in the management of psycho-geriatric patients. Med J Aust 55 /1: 799–802

    Google Scholar 

  25. Gaitz CM, Hartford JT (1979) Ergot alkoloids in treatment of geriatric patients with dementia. In: Nandy (ed) Geriatric psychopharmacology. Elsevier North Holland, New York Oxford, pp 213–223

    Google Scholar 

  26. Gaitz CM, Scott J (1972) Age and the measurement of mental health. J Health Soc Behav 13: 55–67

    Article  PubMed  CAS  Google Scholar 

  27. Gaitz CM, Varner RV, Overall JE (1977) Pharmacotherapy for organic brain syndrome in late life evaluation of an ergot derivative va placebo. Arch Gen Psychiatry 34: 5–11

    Google Scholar 

  28. Gedye JL, Ibrahimi GS, McDonald C (1978) A double-blind controlled trial of piracetam (2- pyrrolidone acetamide) on two groups of psychogeriatric patients. IRCS Med Sci Clin Med 6 /5: 202

    Google Scholar 

  29. Georges D, Lallemand A, Coustenoble J, Loria Y (1977) Validation by factor analysis of a rating scale in cerebral insufficiency in the elderly. Therapie 32 /2: 173–180

    PubMed  CAS  Google Scholar 

  30. Gerin J (1969) Symptomatic treatment of cerebrovascular insufficiency with hydergine. Curr Ther Res 11: 539–546

    PubMed  CAS  Google Scholar 

  31. Goga JA, Hambacher WO (1977) Psychologic and behavioral assessment of geriatric patients: A review. J Am Geriatr Soc 25 /5: 232–237

    PubMed  CAS  Google Scholar 

  32. Goldstein SE, Birnbom F (1979) Nylidrin HCL in the treatment of symptoms of the aged: A double-blind placebo controlled study. J Clin Psychiatry 40 /12: 520–524

    PubMed  CAS  Google Scholar 

  33. Harwart D (1979) The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxyifylline. („TRENTAL“ 400). Curr Med Res Opin 6 /2: 73–84

    Article  PubMed  CAS  Google Scholar 

  34. Haskovec L, Jirak R, Srutova L (1977) Organisches Psychosyndrom im Alter. Ergebnisse einer klinischen Doppelblindprüfung. Ärztl Prax 3959: 3–13

    Google Scholar 

  35. Lino K, Abe K, Kariya S et al. (1977) A controlled, double-blind study of dl-alpha-tocopheryl nicotinate (juvela-nicotinate) for treatment of symptoms in hypertension and cerebral arteriosklerosis. Jpn Heart J 17: 277–286

    Google Scholar 

  36. Jacobs M, Trommel J, Gips CH (1978) A rating scale for geriatric patients; need of care, age groups and one-year survival of psychogeriatric patients. Ned Tijdschr Gerontol 9 /1: 27–34

    Google Scholar 

  37. Jennings WG (1972) An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: Double-blind study. J Am Geriatr Soc 20 /8: 407–412

    PubMed  CAS  Google Scholar 

  38. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185: 914–919

    PubMed  CAS  Google Scholar 

  39. Kretschmar JH, Kretschmar C (1976) Zur Dosis-Wirkungs-Relation bei der Behandlung mit Piracetam (Sonderdruck). Arzneimittelforsch 26 /6: 1158–1159

    PubMed  CAS  Google Scholar 

  40. Magnus RV (1978) A controlled trial of chlormethiazole in the management of symptoms of the organic dementias in the elderly. Clin Ther 1/6/387–396

    Google Scholar 

  41. Matejcek M, Knor K, Piguet P-V, Weil C (1979) Electroencephalographic and clinical changes as correlated in geriatric patients treated three month with an ergot alkaloid preparation. J Am Geriatr Soc 27: 198–202

    PubMed  CAS  Google Scholar 

  42. McConnachie RW (1973) A clinical trial comparing „hydergine“ with placebo in the treatment of cerebrovascular insufficiency in elderly patients. Curr Med Res Opin 1 /8: 463–468

    Article  PubMed  CAS  Google Scholar 

  43. Miller ER, Parachek JF (1974) Validation and standardization of a goal-oriented, quick-screening geriatric scale. J Am Geriatr Soc 22 /6: 278–283

    PubMed  CAS  Google Scholar 

  44. Misurec J, Slama B, Nahunek K (1976) Pyrithioxin/Encephabol/bei der Behandlung von Patienten mit organischem Psychosyndrom in der Involution. CS Psychiatrie 72 /1: 14–23

    CAS  Google Scholar 

  45. Nelson JJ (1975) Relieving select symptoms of the elderly. Geriatrics 30: 133

    PubMed  CAS  Google Scholar 

  46. Norton JC, Romano PO, Sandifer MG (1977) The ward function inventory (WFI): A scale for use with geriatric and demented inpatients. Dis Nerv Syst 38 /1: 20–23

    PubMed  CAS  Google Scholar 

  47. Rao DB, Norris JR (1972) A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly. John Hopkins Med J 130: 317–323

    CAS  Google Scholar 

  48. Rao DB, Georgiev EL, Paul PD, Guzman AB (1977) Cyclandelate in the treatment of senile mental changes: A double-blind evaluation. J Am Geriatr Soc 25: 548–551

    PubMed  CAS  Google Scholar 

  49. Rehman SA (1973) Two trials comparing,hydergine‘ with placebo in the treatment of patients suffering from cerebrovascular insufficiency. Curr Med Res Opin 1 /8: 456–462

    Article  PubMed  CAS  Google Scholar 

  50. Rosen HJ (1972) Chronic cerebrovascular insufficiency in the elderly (Perspectives on treatment). J Med Soc NJ 69 /5: 445–448

    CAS  Google Scholar 

  51. Rosen HJ (1975) Mental decline in the elderly: Pharmacotherapy (Ergot alkaloids versus papaverine). J Am Geriatr Soc 23 /4: 169–174

    PubMed  CAS  Google Scholar 

  52. Salzman C, Shader RI, Kochansky GE, Cronin DM (1972) Rating scales for psychotropic drug research with geriatric patients: I. Behavior ratings. J Am Geriatr Soc 20 /5: 209–214

    PubMed  CAS  Google Scholar 

  53. Salzman C, Kochansky GE, Shader RI, Cronin DM (1972) Rating scales for psychotropic drug research with geriatric patients: II. Mood ratings. J Am Geriatr Soc 20 /5: 215–221

    PubMed  CAS  Google Scholar 

  54. Salzman C, Kochansky GE, Shader RI (1972) Rating scales for geriatric psychopharmacology: A review. Psychopharmacol Bull 8 /3: 3–50

    PubMed  CAS  Google Scholar 

  55. Schubert H, Fleischhacker W (1979) Therapeutische Ansätze bei dementieilen Syndromen. Ärztl Prax 46:2157–2160 (Sonderdruck)

    Google Scholar 

  56. Shader RI, Harmatz JS, Salzman C (1974) A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment-Geriatric (SCAG). J Am Geriatr Soc 22 /3: 107–113

    PubMed  CAS  Google Scholar 

  57. Triboletti F, Fern H (1969) Hydergine for treatment of symptoms of cerebrovascular insufficiency. Curr Ther Res 11 /10: 609–620

    PubMed  CAS  Google Scholar 

  58. Wilde M, Angleitner A, Rönn C, Kieburg H (1978) Psychologische Testverfahren im Doppelblindversuch bei geriatrischen Patienten. Therapiewoche 28: 6577–6588

    Google Scholar 

Download references

Authors
  1. E. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Heinrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Quadbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Tegeler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. C. u. O. Vogt-Instituts für Hirnforschung, Universität Düsseldorf, Moorenstraße 5, D-4000, Düsseldorf 1, Germany

    Adolf Hopf (Direktor des C. u. O. Vogt-Instituts für Hirnforschung der Universität Düsseldorf) (Direktor des C. u. O. Vogt-Instituts für Hirnforschung der Universität Düsseldorf)

  2. Landesstiftung des öffentlichen Rechts, Psychiatrische Klinik, Zentralinstitut für Seelische Gesundheit ZI Mannheim, Postfach 5970, D-6800, Mannheim 1, Germany

    Helmut Beckmann

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lehmann, E., Heinrich, K., Quadbeck, H., Tegeler, J. (1984). Güteeigenschaften gerontopsychiatrischer Skalen. In: Hopf, A., Beckmann, H. (eds) Forschungen zur Biologischen Psychiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69539-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69539-1_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13130-4

  • Online ISBN: 978-3-642-69539-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation